{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:27Z","timestamp":1790610807386,"version":"4.1.0"},"reference-count":0,"publisher":"Clinical Care Targeted Communications Group, LLC","issue":"Suppl 9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.37765\/ajmc.2024.89635","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T14:00:37Z","timestamp":1731074437000},"page":"S159-S174","source":"Crossref","is-referenced-by-count":18,"title":["Management strategies for metabolic dysfunction\u2013associated steatotic liver disease (MASLD)"],"prefix":"10.37765","volume":"30","member":"24492","published-online":{"date-parts":[[2024,11,7]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T14:00:39Z","timestamp":1731074439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/management-strategies-for-metabolic-dysfunction-associated-steatotic-liver-disease-masld-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":0,"journal-issue":{"issue":"Suppl 9","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2024.89635","archive":["Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}